August 2024—Roche has launched the Ventana Kappa and Lambda Dual ISH mRNA Probe Cocktail assay in countries accepting the CE mark. The assay is intended for the qualitative detection of kappa and lambda mRNA in formalin-fixed, paraffin-embedded human bone marrow and lymphoid tissue stained on a BenchMark IHC/ISH instrument using chromogenic in situ hybridization and visualized using light microscopy. The test is intended as an aid in the identification of B-cell lymphomas and plasma cell neoplasms. The results of the assay should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. The product is intended for in vitro diagnostic use.
Roche, +41 61 688 1111